Risk factors for postoperative urinary retention in fragility hip fracture patients: a prospective study
Issued Date
2024-06-03
Resource Type
eISSN
14712318
Scopus ID
2-s2.0-85195013233
Pubmed ID
38831267
Journal Title
BMC geriatrics
Volume
24
Issue
1
Rights Holder(s)
SCOPUS
Bibliographic Citation
BMC geriatrics Vol.24 No.1 (2024) , 483
Suggested Citation
Tantigate D., Jansatjawan N., Adulkasem N., Ramart P., Riansuwan K. Risk factors for postoperative urinary retention in fragility hip fracture patients: a prospective study. BMC geriatrics Vol.24 No.1 (2024) , 483. doi:10.1186/s12877-024-05101-2 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/98690
Title
Risk factors for postoperative urinary retention in fragility hip fracture patients: a prospective study
Author's Affiliation
Corresponding Author(s)
Other Contributor(s)
Abstract
BACKGROUND: Postoperative urinary retention (POUR) among older patients with hip fractures is common and may result in delayed ambulation, prolonged hospital stays, and urinary tract infections. Although preoperative urinary catheter indwelling and early postoperative removal can prevent perioperative urinary retention, this condition may occur in some patients after catheter removal, which requires urinary catheter re-indwelling or intermittent catheterization. Therefore, this study aims to identify risk factors and develop a screening tool for postoperative urinary retention in patients who have undergone operative treatment for fragility hip fractures subsequent to urinary catheter removal. METHODS: A prospective cohort study of 145 fragility hip fracture in older patients who were operatively treated between September 2020 and May 2022 was conducted. All patients were evaluated for urine retention after urinary catheter removal using a bladder scan. In addition, factors related to urinary retention were collected and utilized for screening tool development. RESULTS: Of the included patients, 22 (15.2%) were diagnosed with POUR. A multivariable logistic regression model using a stepwise backward elimination algorithm identified the current use of drugs with anticholinergic effect (OR = 11.9, p = 0.012), international prostate symptom score (IPSS) ≥ 8 (OR = 9.3, p < 0.001), and inability to independently get out of bed within 24 h postoperatively (OR = 6.5, p = 0.051) as risk factors of POUR. The screening tool that has been developed revealed an excellent performance (AuROC = 0.85, 95%CI 0.75 to 0.91) with good calibration and minimal optimism. CONCLUSIONS: Current use of drugs with anticholinergic effects, IPSS ≥ 8, and inability to independently get out of bed within 24 h postoperatively are significant variables of POUR. For additional external validation, a proposed scoring system for POUR screening was developed. TRIAL REGISTRATION: The study protocol was retrospectively registered in The Thai Clinical Trials Registry (TCTR20220502001: 2 May 2022).